Should I Buy ASPS? ASPS 2026 Analysis

Should You Buy Altisource Portfolio Solutions SA (ASPS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

5.880

1 Day change

5.19%

52 Week Range

15.960

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: price is trading below key support (S1 4.574) with bearish momentum still expanding.
Oversold RSI (15) can produce short bounces, but without a reversal signal (MACD still worsening) the odds favor further downside/whipsaw.
Fundamentals are deteriorating (revenue down, losses widening), and there are no bullish institutional/insider or news catalysts to justify an aggressive entry.
Next meaningful catalyst is earnings (2026-02-12 pre-market); with an impatient profile, this setup does not offer an attractive risk/reward entry today.

Technical Analysis

Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating sustained downside pressure across long/medium/short horizons.
Momentum: MACD histogram -0.0613 and negatively expanding → downside momentum is strengthening, not stabilizing.
RSI: RSI_6 at 15.144 (deep oversold) → a dead-cat bounce is possible, but oversold alone is not a buy signal while MACD and MAs remain bearish.
Key levels: Current pre-market 4.32 is below S1 (4.574); next support S2 at 4.121. Resistance/pivot above at 5.308, then 6.041.
Pattern-based odds: Model suggests +0.75% next day but -0.94% next week and -1.37% next month → near-term bounce risk, but broader bias remains down.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

- Potential technical oversold bounce due to RSI at extreme lows.
- Upcoming earnings on 2026-02-12 (pre-market) could act as a volatility catalyst if results surprise positively.

Neutral/Negative Catalysts

- Price broke below the S1 support (4.574), increasing probability of a move toward S2 (4.121).
- Bearish moving-average stack and deteriorating MACD momentum suggest the downtrend is still intact.
- No recent news-driven catalyst to shift sentiment.
- Trading trends: hedge funds neutral and insiders neutral (no supportive accumulation signal).
- No recent congress trading data available (no external influential buying signal).

Financial Performance

Latest quarter: 2025/Q3.
Revenue: 24.647M, down 1.40% YoY (continued top-line softness).
Net income: -2.396M, down 74.41% YoY (losses widened materially).
EPS: -0.22, down 91.57% YoY (sharp deterioration in per-share profitability).
Gross margin: 54.85%, down 4.72% YoY (margin compression adds pressure to future profitability).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating / price target change data provided in the dataset, so no recent trend can be confirmed.
Wall Street pros/cons view cannot be substantiated from the provided data; based on available fundamentals/technicals, the cons (downtrend + worsening earnings profile) currently dominate.

Analyst Rating

Wall Street analysts forecast ASPS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold